Type 1 diabetes is an autoimmune disease in which the insulin-producing pancreatic beta cells
are destroyed, resulting in poor blood sugar control. The purpose of this study is to
determine the safety and effectiveness of islet transplantation using a steroid-free,
calcineurin-inhibitor-free belatacept based immunosuppressive medication, for treating type 1
diabetes in individuals experiencing hypoglycemia unawareness and severe hypoglycemic
episodes.
Phase:
Phase 2
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)